Maryland Capital Management Invitae Corp Transaction History

Maryland Capital Management

  • $1.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$14.7 - $28.67 $110,793 - $216,085
-7,537 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$24.31 - $33.6 $25,355 - $35,044
1,043 Added 16.06%
7,537 $214,000
Q2 2021

Aug 13, 2021
SELL
$26.09 - $40.4 $5,270 - $8,160
-202 Reduced 3.02%
6,494 $219,000
Q1 2021

May 11, 2021
BUY
$33.06 - $56.93 $221,369 - $381,203
6,696 New
6,696 $256,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Maryland Capital Management Portfolio

Follow Maryland Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email